The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis
Open accessAbstract
Objective : To compare the efficacy and safety of low molecular weight heparins and unfractionated heparin in the initial treatment of deep venous thrombosis for the reduction of recurrent thromboembolic events, death, extension of thrombus, and haemorrhages. Design : Meta-analysis of results from 16 randomised controlled clinical studies. Subjects : 2045 patients with established deep20venous thrombosis. Intervention : Treatment with low molecular weight heparins or unfractionated heparin. Main outcome measures : Incidences of thromboembolic events (deep venous thrombosis or pulmonary embolism, or both); major haemorrhages; total mortality; and extension of thrombus. Results : A significant reduction in the incidence20of thrombus extension (common odds ratio 0.51, 95% confidence interval 0.32 to 0.83; P=0.006) in favour of low molecular weight heparin was observed. Non-significant trends also in favour of the low molecular weight heparins were observed for the recurrence of thromboembolic events (0.66, 0.41 to 1.07; P=0.09), major haemorrhages (0.65, 0.36 to 1.16; P=0.15), and total mortality (0.72, 0.46 to 1.4; P=0.16). Conclusions : Low molecular weight heparins seem to have a higher benefit to risk ratio than unfractionated heparin in the treatment of venous thrombosis. These results, however, remain to be confirmed by using clinical outcomes in suitably powered clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Beta blockade during and after myocardial infarction: An overview of the randomized trials
Yusuf, S., Peto, R., Lewis, J., Collins, R., & Sleight, P. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(85)80003-7 · Cited by 3,205
ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM
Barritt, D. W., & Jordan, S. C. (1960) · The Lancet · doi:10.1016/s0140-6736(60)92299-6 · Cited by 1,354
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140
Kennedy, C. O. (1971) · British Homeopathic Journal · doi:10.1016/s0007-0785(71)80027-3 · Cited by 974
Hull, R. D., Raskob, G. E., Pineo, G. F., Green, D., Trowbridge, A. A., Elliott, C. G., Lerner, R. G., Hall, J., Sparling, T., Brettell, H. R., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204093261502 · Cited by 700
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
Prandoni, P., Lensing, A. W. A., Büller, H. R., Cogo, A., Prins, M. H., Cattelan, A. M., Cuppini, S., Noventa, F., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210153271604 · Cited by 680
Nurmohamed, M. T., Buller, H. R., Dekker, E., Hommes, D. W., Rosendaal, F. R., Briet, E., Rosendaal, F. R., & Vandenbroucke, J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)93223-a · Cited by 668
Prandoni, P., Carta, M., Cogo, A., Ruol, A., Vigo, M., Casara, D., Lensing, A. W. A., Büller, H. R., & ten Cate, J. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)91054-c · Cited by 583
Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous Thrombosis
Hull, R. D., Raskob, G. E., Rosenbloom, D., Panju, A. A., Brill-Edwards, P., Ginsberg, J. S., Hirsh, J., Martin, G. J., & Green, D. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221802 · Cited by 505
Thompson, S. G., & Pocock, S. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)91975-z · Cited by 487
Brandjes, D. P. M., Heijboer, H., Büller, H. R., de Rijk, M., Jagt, H., & ten Cate, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211193272103 · Cited by 480
A comparison of statistical methods for combining event rates from clinical trials
Berlin, J. A., Laird, N. M., Sacks, H. S., & Chalmers, T. C. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080202 · Cited by 420
Epidemiology of chronic venous ulcers
Baker, S. R., Stacey, M. C., Jopp-McKay, A. G., Hoskin, S. E., & Thompson, P. J. (1991) · Journal of British Surgery · doi:10.1002/bjs.1800780729 · Cited by 400
Incidence of venous thromboembolism verified by necropsy over 30 years.
Lindblad, B., Sternby, N. H., & Bergqvist, D. (1991) · BMJ · doi:10.1136/bmj.302.6778.709 · Cited by 386
Low molecular weight heparin in prevention of perioperative thrombosis.
Leizorovicz, A., Haugh, M. C., Chapuis, F. R., Samama, M. M., & Boissel, J. P. (1992) · BMJ · doi:10.1136/bmj.305.6859.913 · Cited by 378
Self-citationCarter, C., Kelton, J., Hirsh, J., Cerskus, A., Santos, A., & Gent, M. (1982) · Blood · doi:10.1182/blood.v59.6.1239.1239 · Cited by 331
Gallus, A., Tillett, J., Jackaman, J., Mills, W., & Wycherley, A. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91431-5 · Cited by 305
Maggioni, A. P., Franzosi, M. G., Santoro, E., White, H., Van de Werf, F., & Tognoni, G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270101 · Cited by 281
Marder, V. J., Soulen, R. L., Atichartakarn, V., Budzynski, A. Z., Parulekar, S. G., Kim, J. R., Edward, N., Zahavi, J., & Algazy, K. M. (1977) · PubMed · Cited by 266
Simonneau, G. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410130045005 · Cited by 232
Self-citationSurrogate endpoints: A basis for a rational approach
Boissel, J. P., Collet, J. P., Moleur, P., & Haugh, M. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf02333016 · Cited by 166
Self-citationFrydman, A. M., Bara, L., Roux, Y. H., Woler, M., Chauliac, F., & Samama, M. M. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03184.x · Cited by 166
Hommes, D. W., Bura, A., Mazzolai, L., Büller, H. R., & ten Cate, J. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-4-279 · Cited by 163
Occult Malignant Neoplasm in Patients With Deep Venous Thrombosis
Goldberg, R. J. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.2.251 · Cited by 159
A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein Thrombosis
Arnesen, H., Heilo, A., Jakobsen, E., Ly, B., & Skaga, E. (1978) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1978.tb14908.x · Cited by 158
Ninet, J., Bachet, P., Prandoni, P., Ruol, A., Vigo, M., Barret, A., Mericq, O., Boneu, B., Janvier, G., Duroux, P., et al. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647660 · Cited by 148
Bratt, G., Åberg, W., Johansson, M., Törnebohm, E., Granqvist, S., & LOCKNER, D. (1990) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1647348 · Cited by 147
Łopaciuk, S., Meissner, A. J., Filipecki, S., Zawilska, K., Sowier, J., Ciesielski, L., Bielawiec, M., Głowiński, S., Częstochowska, E., & others (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656309 · Cited by 145
Considerations for the meta-analysis of randomized clinical trials
Boissel, J., Blanchard, J., Panak, E., Peyrieux, J., & Sacks, H. S. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90067-6 · Cited by 119
Self-citationHauck, W. W., Anderson, S., & Leahy, F. J. (1982) · Journal of the American Statistical Association · doi:10.1080/01621459.1982.10477778 · Cited by 63
Faivre, R., Neuhart, Y., Kieffer, Y., Apffel, F., Magnin, D., Didier, D., Toulemonde, F., Bassand, J., & Jp, M. (1988) · PubMed · Cited by 36
Chalmers, I., Stewart, L., Girling, D. J., Parmar, M. B., & Machin, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92771-s · Cited by 34
Meta-analysis and multiple publication of clinical trial reports
Leizorovicz, A., Haugh, M. C., & Boissel, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)93126-8 · Cited by 27
Self-citation
Cited by
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., Warkentin, T. E., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (1998) · Chest · doi:10.1378/chest.114.5_supplement.489s · Cited by 1,031
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
(1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371001 · Cited by 784
Simonneau, G., Sors, H., Charbonnier, B., Page, Y., Laaban, J.-P., Azarian, R., Laurent, M., Hirsch, J.-L., Ferrari, E., Bosson, J.-L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371002 · Cited by 782
Self-citationLow-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
Metadata
- Authors
- Leizorovicz, A., Simonneau, G., Decousus, H., & Boissel, J. P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1994-07-30
- Volume
- 309
- Issue
- 6950
- Pages
- 299-304
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2034586141
- Cited by
- 306
- References
- 37
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.